BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37851071)

  • 1. Intraoperative Integrated Diagnostic System for Malignant Central Nervous System Tumors.
    Hayashi T; Tateishi K; Matsuyama S; Iwashita H; Miyake Y; Oshima A; Honma H; Sasame J; Takabayashi K; Sugino K; Hirata E; Udaka N; Matsushita Y; Kato I; Hayashi H; Nakamura T; Ikegaya N; Takayama Y; Sonoda M; Oka C; Sato M; Isoda M; Kato M; Uchiyama K; Tanaka T; Muramatsu T; Miyake S; Suzuki R; Takadera M; Tatezuki J; Ayabe J; Suenaga J; Matsunaga S; Miyahara K; Manaka H; Murata H; Yokoyama T; Tanaka Y; Shuto T; Ichimura K; Kato S; Yamanaka S; Cahill DP; Fujii S; Shankar GM; Yamamoto T
    Clin Cancer Res; 2024 Jan; 30(1):116-126. PubMed ID: 37851071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic algorithm for pathological evaluation of gliomas in a resource-constrained setting.
    Jain S; Gupta P; Shankar KB; Singh R; Siraj F
    J Cancer Res Ther; 2023; 19(3):562-566. PubMed ID: 37470575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applications of molecular neuro-oncology - a review of diffuse glioma integrated diagnosis and emerging molecular entities.
    Wood MD; Halfpenny AM; Moore SR
    Diagn Pathol; 2019 Apr; 14(1):29. PubMed ID: 30967140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Essentials of Molecular Testing in CNS Tumors: What to Order and How to Integrate Results.
    Feldman AZ; Jennings LJ; Wadhwani NR; Brat DJ; Horbinski CM
    Curr Neurol Neurosci Rep; 2020 May; 20(7):23. PubMed ID: 32445025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the Diagnostic Utility of Serum MicroRNA Classification in Patients With Diffuse Glioma.
    Ohno M; Matsuzaki J; Kawauchi J; Aoki Y; Miura J; Takizawa S; Kato K; Sakamoto H; Matsushita Y; Takahashi M; Miyakita Y; Ichimura K; Narita Y; Ochiya T
    JAMA Netw Open; 2019 Dec; 2(12):e1916953. PubMed ID: 31808923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Laboratory Testing Practices in Diffuse Gliomas Prior to Publication of 2021 World Health Organization Classification of Central Nervous System Tumors.
    Ramkissoon SH; Fernandes H; Lopez-Terrada DH; Hameed MR; Trembath DG; Bridge JA; Lindeman NI; Souers RJ; Vasalos P; Brat DJ; Moncur JT
    Arch Pathol Lab Med; 2022 May; 147(5):518-524. PubMed ID: 35878398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of genome-wide DNA methylation profiling for pediatric-type diffuse gliomas.
    Otani Y; Satomi K; Suruga Y; Ishida J; Fujii K; Ichimura K; Date I
    Brain Tumor Pathol; 2023 Apr; 40(2):56-65. PubMed ID: 37004583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraoperative pathologic diagnosis of central nervous system lymphomas: A comparison of frozen and permanent section diagnoses, and the significance of preoperative imaging.
    Kahraman A; Dirilenoğlu F; Güzeliş İ; Çetinoğlu K
    Ann Diagn Pathol; 2024 Apr; 69():152246. PubMed ID: 38113550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Same-day genomic and epigenomic diagnosis of brain tumors using real-time nanopore sequencing.
    Euskirchen P; Bielle F; Labreche K; Kloosterman WP; Rosenberg S; Daniau M; Schmitt C; Masliah-Planchon J; Bourdeaut F; Dehais C; Marie Y; Delattre JY; Idbaih A
    Acta Neuropathol; 2017 Nov; 134(5):691-703. PubMed ID: 28638988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted Next-Generation Sequencing in Molecular Subtyping of Lower-Grade Diffuse Gliomas: Application of the World Health Organization's 2016 Revised Criteria for Central Nervous System Tumors.
    Carter JH; McNulty SN; Cimino PJ; Cottrell CE; Heusel JW; Vigh-Conrad KA; Duncavage EJ
    J Mol Diagn; 2017 Mar; 19(2):328-337. PubMed ID: 28042970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gliomas in children and adolescents: investigation of molecular alterations with a potential prognostic and therapeutic impact.
    Cabral de Carvalho Corrêa D; Tesser-Gamba F; Dias Oliveira I; Saba da Silva N; Capellano AM; de Seixas Alves MT; Dastoli PA; Cavalheiro S; Caminada de Toledo SR
    J Cancer Res Clin Oncol; 2022 Jan; 148(1):107-119. PubMed ID: 34626238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WES data from 286 diffuse gliomas under the 2021 WHO Classification of Tumors of the Central Nervous System.
    Zhao Z; Zhang KN; Sun Z; Yang C; Wang Q; Li G; Wang Z; Zeng F; Chai R; Qian Z; Wang Z; Liu Y; Ma W; Wu F; Jiang T
    Sci Data; 2022 Nov; 9(1):692. PubMed ID: 36369198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of intraoperative consultation for the diagnosis of central nervous system lesions and evaluation of its diagnostic accuracy.
    Modi M; Nilkanthe R; Trivedi P; Shah A; Shah J; Chaudhari J
    J Cancer Res Ther; 2018; 14(6):1176-1179. PubMed ID: 30488825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2021 updates to the World Health Organization classification of adult-type and pediatric-type diffuse gliomas: a clinical practice review.
    Thomas DL
    Chin Clin Oncol; 2023 Feb; 12(1):7. PubMed ID: 36922356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel all-in-one intraoperative genotyping system for IDH1-mutant glioma.
    Ohka F; Yamamichi A; Kurimoto M; Motomura K; Tanahashi K; Suzuki H; Aoki K; Deguchi S; Chalise L; Hirano M; Kato A; Nishimura Y; Hara M; Kato Y; Wakabayashi T; Natsume A
    Brain Tumor Pathol; 2017 Apr; 34(2):91-97. PubMed ID: 28353033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A rapid genotyping panel for detection of primary central nervous system lymphoma.
    Gupta M; Burns EJ; Georgantas NZ; Thierauf J; Nayyar N; Gordon A; Jones SS; Pisapia M; Sun Y; Burns RP; Velarde J; Jordan JT; Frigault MJ; Nahed BV; Jones PS; Barker FG; Curry WT; Gupta R; Batchelor TT; Romero JM; Brastianos PK; Marble HD; Martinez-Lage M; Tateishi K; Lennerz JK; Dietrich J; Cahill DP; Carter BS; Shankar GM
    Blood; 2021 Aug; 138(5):382-386. PubMed ID: 33735913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precision Neuro-oncology: the Role of Genomic Testing in the Management of Adult and Pediatric Gliomas.
    Ramkissoon LA; Britt N; Guevara A; Whitt E; Severson E; Sathyan P; Gay L; Elvin J; Ross JS; Brown C; Stogner-Underwood K; Mott R; Kram D; Strowd R; Lesser GJ; Ramkissoon SH
    Curr Treat Options Oncol; 2018 Jun; 19(8):41. PubMed ID: 29931654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ATRX immunostaining predicts IDH and H3F3A status in gliomas.
    Ebrahimi A; Skardelly M; Bonzheim I; Ott I; Mühleisen H; Eckert F; Tabatabai G; Schittenhelm J
    Acta Neuropathol Commun; 2016 Jun; 4(1):60. PubMed ID: 27311324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frozen section discrepancy in the evaluation of central nervous system tumors.
    Plesec TP; Prayson RA
    Arch Pathol Lab Med; 2007 Oct; 131(10):1532-40. PubMed ID: 17922589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid immunohistochemistry based on alternating current electric field for intraoperative diagnosis of brain tumors.
    Tanino M; Sasajima T; Nanjo H; Akesaka S; Kagaya M; Kimura T; Ishida Y; Oda M; Takahashi M; Sugawara T; Yoshioka T; Nishihara H; Akagami Y; Goto A; Minamiya Y; Tanaka S;
    Brain Tumor Pathol; 2015 Jan; 32(1):12-9. PubMed ID: 24807101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.